Works by Huang, Hui-qiang


Results: 49
    1
    2
    3
    4
    5

    Risk‐based, response‐adapted therapy for early‐stage extranodal nasal‐type NK/T‐cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 9, p. 1047, doi. 10.1002/ajh.25878
    By:
    • Qi, Shu‐Nan;
    • Yang, Yong;
    • Zhang, Yu‐Jing;
    • Huang, Hui‐Qiang;
    • Wang, Ying;
    • He, Xia;
    • Zhang, Li‐Ling;
    • Wu, Gang;
    • Qu, Bao‐Lin;
    • Qian, Li‐Ting;
    • Hou, Xiao‐Rong;
    • Zhang, Fu‐Quan;
    • Qiao, Xue‐Ying;
    • Wang, Hua;
    • Li, Gao‐Feng;
    • Zhu, Yuan;
    • Cao, Jian‐Zhong;
    • Wu, Jun‐Xin;
    • Wu, Tao;
    • Zhu, Su‐Yu
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    A TNM Staging System for Nasal NK/T-Cell Lymphoma.

    Published in:
    PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130984
    By:
    • Yan, Zheng;
    • Huang, Hui-qiang;
    • Wang, Xiao-xiao;
    • Gao, Yan;
    • Zhang, Yu-jing;
    • Bai, Bing;
    • Zhao, Wei;
    • Jiang, Wen-qi;
    • Li, Zhi-ming;
    • Xia, Zhong-jun;
    • Lin, Su-xia;
    • Xie, Chuan-miao
    Publication type:
    Article
    46
    47
    48
    49